CONTEXT: Both training and normal body mass index are associated with high insulin sensitivity, but the mechanism may be different. OBJECTIVE: The aim of the study was to examine whether lean trained humans may be protected from acute free fatty acid (FFA)-induced insulin resistance compared with lean sedentary humans. DESIGN AND SETTING: We conducted an interventional trial using either a 6-h lipid (20% Intralipid at 90 ml/h) or glycerol (2.25 g/100 ml at 90 ml/h) infusion along with a concurrent hyperinsulinemic-euglycemic clamp and serial muscle biopsies (0, 120, 360 min) at a clinical research unit at the University of Minnesota. PATIENTS OR PARTICIPANTS: The study included lean endurance-trained (n = 14) and sedentary (n = 14) individuals matched for age, gender, and body mass index. MAIN OUTCOME MEASURES: We measured the decline in glucose infusion rate (GIR) during the hyperinsulinemic-euglycemic clamp. RESULTS: The trained group had higher baseline mitochondrial DNA copy number, mRNA of cytochrome C oxidase subunit 3, and insulin sensitivity (as measured by GIR) compared with the sedentary group. When FFA was acutely elevated to the upper physiological range (0.6-0.7 mEq/liter) by lipid infusion, the GIR in both activity groups declined similarly compared with their respective glycerol controls, although insulin signaling, as measured by Ser 473 pAKT/AKT, remained comparable. Specific to the trained group, the stimulatory effect of hyperinsulinemia on mitochondrial mRNA levels during the glycerol infusion was absent during the lipid infusion. CONCLUSIONS: Elevated FFA had similar effects in reducing insulin sensitivity in trained and sedentary humans. In trained participants, this decline was associated with alterations in the skeletal muscle mitochondrial mRNA response to hyperinsulinemia.
CONTEXT: Both training and normal body mass index are associated with high insulin sensitivity, but the mechanism may be different. OBJECTIVE: The aim of the study was to examine whether lean trained humans may be protected from acute free fatty acid (FFA)-induced insulin resistance compared with lean sedentary humans. DESIGN AND SETTING: We conducted an interventional trial using either a 6-h lipid (20% Intralipid at 90 ml/h) or glycerol (2.25 g/100 ml at 90 ml/h) infusion along with a concurrent hyperinsulinemic-euglycemic clamp and serial muscle biopsies (0, 120, 360 min) at a clinical research unit at the University of Minnesota. PATIENTS OR PARTICIPANTS: The study included lean endurance-trained (n = 14) and sedentary (n = 14) individuals matched for age, gender, and body mass index. MAIN OUTCOME MEASURES: We measured the decline in glucose infusion rate (GIR) during the hyperinsulinemic-euglycemic clamp. RESULTS: The trained group had higher baseline mitochondrial DNA copy number, mRNA of cytochrome C oxidase subunit 3, and insulin sensitivity (as measured by GIR) compared with the sedentary group. When FFA was acutely elevated to the upper physiological range (0.6-0.7 mEq/liter) by lipid infusion, the GIR in both activity groups declined similarly compared with their respective glycerol controls, although insulin signaling, as measured by Ser 473 pAKT/AKT, remained comparable. Specific to the trained group, the stimulatory effect of hyperinsulinemia on mitochondrial mRNA levels during the glycerol infusion was absent during the lipid infusion. CONCLUSIONS: Elevated FFA had similar effects in reducing insulin sensitivity in trained and sedentary humans. In trained participants, this decline was associated with alterations in the skeletal muscle mitochondrial mRNA response to hyperinsulinemia.
Authors: M Krssak; K Falk Petersen; A Dresner; L DiPietro; S M Vogel; D L Rothman; M Roden; G I Shulman Journal: Diabetologia Date: 1999-01 Impact factor: 10.122
Authors: G Perseghin; T B Price; K F Petersen; M Roden; G W Cline; K Gerow; D L Rothman; G I Shulman Journal: N Engl J Med Date: 1996-10-31 Impact factor: 91.245
Authors: Kostas Tsintzas; Kamal Chokkalingam; Kirsty Jewell; Luke Norton; Ian A Macdonald; Dumitru Constantin-Teodosiu Journal: J Clin Endocrinol Metab Date: 2007-07-24 Impact factor: 5.958
Authors: John J Dubé; Francesca Amati; Maja Stefanovic-Racic; Frederico G S Toledo; Sarah E Sauers; Bret H Goodpaster Journal: Am J Physiol Endocrinol Metab Date: 2008-03-04 Impact factor: 4.310
Authors: Simon Schenk; Matthew P Harber; Cara R Shrivastava; Charles F Burant; Jeffrey F Horowitz Journal: J Physiol Date: 2009-09-01 Impact factor: 5.182
Authors: Ian R Lanza; Daniel K Short; Kevin R Short; Sreekumar Raghavakaimal; Rita Basu; Michael J Joyner; Joseph P McConnell; K Sreekumaran Nair Journal: Diabetes Date: 2008-08-20 Impact factor: 9.461
Authors: Lisa S Chow; Douglas G Mashek; Erin Austin; Lynn E Eberly; Xuan-Mai Persson; Mara T Mashek; Elizabeth R Seaquist; Michael D Jensen Journal: Am J Physiol Endocrinol Metab Date: 2014-05-20 Impact factor: 4.310
Authors: Andrea Santi; Tyler A Bosch; Anne E Bantle; Alison Alvear; Qi Wang; James S Hodges; Donald R Dengel; Lisa S Chow Journal: Metab Syndr Relat Disord Date: 2018-08-21 Impact factor: 1.894
Authors: John J Dubé; Paul M Coen; Giovanna DiStefano; Alexander C Chacon; Nicole L Helbling; Marisa E Desimone; Maja Stafanovic-Racic; Kazanna C Hames; Alex A Despines; Frederico G S Toledo; Bret H Goodpaster Journal: Am J Physiol Endocrinol Metab Date: 2014-10-28 Impact factor: 4.310
Authors: Jacob T Seibert; Charles P Najt; Timothy D Heden; Douglas G Mashek; Lisa S Chow Journal: Trends Endocrinol Metab Date: 2020-09-08 Impact factor: 12.015
Authors: Lu Zheng; Yuehua Feng; Yuanping Shi; Jun Zhang; Qinfeng Mu; Li Qin; Maria Berggren-Söderlund; Peter Nilsson-Ehle; Xiaoying Zhang; Guanghua Luo; Ning Xu Journal: PLoS One Date: 2014-08-21 Impact factor: 3.240